Synchronous Lung Adenocarcinomas with Unique MET Exon14 Skipping Alterations in a Patient with Pathogenic Germline NBN Variant

Case Presenter(s)

• JW

  Jonathan Willner, MD (he/him/his)

  Molecular Pathology Fellow
  Memorial Sloan Kettering Cancer Center
  West Hempstead, New York, United States